Connected Health to Decrease Opioid Use in Patients With Chronic Pain
NCT04013529 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2021-10-27
Summary
The objective of this pilot study to evaluate if behavioral incentives applied at the VA Medical Center can appreciably increase participation in activities that promote mobility, and subsequently reduce pain severity and opioid use.
Conditions
Interventions
- BEHAVIORAL
-
Regret lottery
Subjects who achieve step goals are entered into a lottery in which they can win a financial incentive of $30 or $100.
- BEHAVIORAL
-
Way to Health technology enhanced care
Subjects receive text reminders to reach activity goals.
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-31
- Primary Completion
- 2020-09-15
- Completion
- 2020-09-15
Countries
- United States
Study Locations
More Related Trials
-
User Acceptability of a Device-Based Opioid Overdose Intervention
NCT04530591 ·Status: COMPLETED
-
Endocannabinoids, Stress, Craving And Pain Effects Study
NCT05480072 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Mobile & Online-Based Interventions to Lessen Pain
NCT05152134 ·Status: COMPLETED ·Phase: PHASE3
-
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
NCT05336188 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Health Outcomes From Opioid Therapy for Chronic Pain
NCT00495404 ·Status: COMPLETED ·Phase: NA
-
A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain
NCT02751762 ·Status: COMPLETED
-
Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain
NCT02276989 ·Status: WITHDRAWN ·Phase: PHASE2
-
PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Current Opioid-User Population
NCT04601480 ·Status: COMPLETED ·Phase: NA
-
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
NCT00781898 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
BE Intervention for Naloxone Uptake
NCT06064981 ·Status: COMPLETED ·Phase: NA
-
Negating Opioid and Pain Actively Through Intervention
NCT03306147 ·Status: COMPLETED ·Phase: NA
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Understanding Treatment Response With Naltrexone Among White Alcoholics
NCT00817089 ·Status: COMPLETED ·Phase: PHASE4
-
Collaborative Care for Opioid Dependence And Pain Pilot Study
NCT04121546 ·Status: TERMINATED ·Phase: NA
-
Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder
NCT06086275 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase)
NCT04278586 ·Status: COMPLETED ·Phase: NA
-
Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
NCT03821103 ·Status: COMPLETED ·Phase: NA
-
Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study
NCT04656899 ·Status: COMPLETED ·Phase: NA
-
Effects of Environmental Factors on Opiate Drug Choice in Opioid Dependent Individuals.
NCT00608504 ·Status: COMPLETED
-
Inpatient Multimodal Path to RecOVEry
NCT03303664 ·Status: WITHDRAWN ·Phase: NA
-
Improving Insomnia in Patients With Opioid Use Disorder
NCT05588726 ·Status: WITHDRAWN ·Phase: NA
-
Pilot Trial of Opioid Taper Support
NCT01883882 ·Status: COMPLETED ·Phase: NA
-
Employment-based Reinforcement of Naltrexone Ingestion and Abstinence
NCT00149669 ·Status: COMPLETED ·Phase: NA
-
Effects of Dronabinol in Opioid Maintained Patients
NCT04025359 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction
NCT00521157 ·Status: COMPLETED ·Phase: PHASE2/PHASE3